Page 507 - 先天性心脏病的导管术：从婴幼儿期到成人期

38 术后残留缺口的闭合 489

[3] Hill KD, Fleming G, Curt Fudge J, Albers EL, Doyle TP, Rhodes JF. Percutaneous in-

terventions in high-risk patients following Mustard repair of transposition of the great
arteries. Catheter Cardiovasc Interv. 2012;80:905-14.
[4] Nguyen HL, Phan QT, Dinh LH, Tran HB, Won H, Thottian JJ, Duc DD, Quang TN,
Kim SW. Percutaneous closure of perimembranous ventricular septal defect using patent

ductus arteriosus occluders. PLoS One. 2018;13(11):e0206535.
[5] El-Sisi A, Sobhy R, Jaccoub V, Hamza H. Perimembranous ventricular septal defect
device closure: choosing between amplatzer duct occluder I and II. Pediatr Cardiol.
2017;38(3):596-602.